Bliss GVS in limelight

Bliss GVS is currently among the top three gainers on the BSE, rising 13% to hit an intraday high at Rs,121.80. Its 20% UC for the day is at Rs.129.10.

The stock is presently on the radar of bargain hunters on the back of good earnings. On a consolidated basis, the company reported a 50% (YoY) rise in net profit at Rs.24 crore on a 30% increase in sales at Rs.168 crore.

Its Operating profit margin showed a healthy jump from 15.04% to 20.58%.

The company is a leading anti-malarial drug maker and its reputation had received a when it was caught importing fake anti-malarial drugs. In March, the High Court of Justice, Ghana granted ex-parte interim relief to the company in a commercial suit for infringement of intellectual property rights and the Registrar has been ordered to seize the infringing products.